Nitazene Control Act of 2025
Sponsor
Full profile: /officials/V000138
Source: Congress.gov · FEC
Cosponsors (30)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
- Michael Baumgartner (R-WA-5)Original· 2025-09-16
- Andy Harris (R-MD-1)· 2025-10-24
- Brian K. Fitzpatrick (R-PA-1)· 2025-11-07
- Donald G. Davis (D-NC-1)· 2025-11-18
- Daniel S. Goldman (D-NY-10)· 2025-11-19
- Richard McCormick (R-GA-7)· 2025-11-19
- David J. Taylor (R-OH-2)· 2025-11-28
- Ryan Mackenzie (R-PA-7)· 2025-12-10
- Deborah K. Ross (D-NC-2)· 2025-12-16
- Glenn Thompson (R-PA-15)· 2025-12-16
- Mike Kelly (R-PA-16)· 2025-12-16
- Pat Harrigan (R-NC-10)· 2025-12-16
- Robert F. Onder, Jr. (R-MO-3)· 2025-12-18
- Robert P. Bresnahan, Jr. (R-PA-8)· 2025-12-18
- Chrissy Houlahan (D-PA-6)· 2025-12-19
- Michael Lawler (R-NY-17)· 2025-12-19
- Joe Neguse (D-CO-2)· 2026-01-07
- Mike Carey (R-OH-15)· 2026-01-07
- August Pfluger (R-TX-11)· 2026-01-12
- Brandon Gill (R-TX-26)· 2026-01-12
- Sam T. Liccardo (D-CA-16)· 2026-01-13
- Susie Lee (D-NV-3)· 2026-01-13
- Derek Schmidt (R-KS-2)· 2026-02-10
- Maria Elvira Salazar (R-FL-27)· 2026-02-13
- James R. Baird (R-IN-4)· 2026-02-20
- Thomas R. Suozzi (D-NY-3)· 2026-03-03
- Randy Fine (R-FL-6)· 2026-04-15
- Russell Fry (R-SC-7)· 2026-04-15
- Maggie Goodlander (D-NH-2)· 2026-04-22
- Matt Van Epps (R-TN-7)· 2026-05-11
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-09-16
Source: Congress.gov
Committee Activity
Currently in
- House Committee on the JudiciaryReferred To · 2025-09-16
- House Committee on Energy and CommerceReferred To · 2025-09-16
Previously
- Energy and Commerce CommitteeReferred To · 2025-09-16
- Judiciary CommitteeReferred To · 2025-09-16
Plain-English Summary
The bill would classify nitazene, a synthetic opioid, as a controlled substance under federal law, making it illegal to manufacture, distribute, or possess without authorization. This would give law enforcement tools to prosecute people involved in nitazene trafficking and production, similar to how they handle other dangerous drugs like fentanyl. The change aims to address the growing public health threat from nitazene, which has been increasingly found in illicit drug supplies and linked to overdose deaths.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR9082To prohibit the use of prediction markets by Department of Defense personnel, and for other purposes.Referred to Committee · 2026-05-29
- HR9042To promote the development, production, and deployment of secure and resilient Unmanned Aerial Systems (UAS) to enhance United States national security and support the defense and resilience of Taiwan in the Indo-Pacific Region.Referred to Committee · 2026-05-26
- HR8947To require the Federal Energy Regulatory Commission to establish and maintain the National Utility Rate Change Tracker, and for other purposes.Referred to Committee · 2026-05-20
- HR8948To amend the Public Utility Regulatory Policies Act of 1978 to require States to consider measures that limit the amount of retail utility rate increases an electric utility can request to once every 365 days.Referred to Committee · 2026-05-20